Qube Research & Technologies (QRT)’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SEEL Stock Details SEEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2	Closed	-$278	–	4964
2023 Q4	$278	Buy	+2	New	+$984	﹤0.01%	3957
2023 Q3	–	Hold	0	–	–	–	4380
2022 Q4	–	Sell	-21	Closed	-$84K	–	3102
2022 Q3	$84K	Sell	21 -3	-13%	-$11.8K	﹤0.01%	2023
2022 Q2	$62K	Buy	+24	New	+$62.5K	﹤0.01%	2079
2021 Q3	–	Sell	-41	Closed	-$418K	–	2897
2021 Q2	$418K	Buy	+41	New	+$674K	﹤0.01%	1373

Other funds holding SEEL

Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

GJL

Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MWM

Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFWC

Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SEEL Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q1 2024, closing a stake of 2 shares — an estimated $278 sold.

Qube Research & Technologies (QRT) first reported a position in SEEL in Q2 2021 and held it in 4 quarters. The position peaked at $418K in Q2 2021. 29 funds tracked by Wall St. Rank hold SEEL as of Q1 2024.

Qube Research & Technologies (QRT) reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 2 Seelos Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $278.
Qube Research & Technologies (QRT) first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Qube Research & Technologies (QRT)'s Seelos Therapeutics, Inc. Common Stock position peaked at $418K in Q2 2021.
29 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.